サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1304503

栄養補助食品成分の世界市場-2023年～2030年

Global Nutraceutical Ingredients Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
栄養補助食品成分の世界市場-2023年～2030年
出版日: 2023年07月07日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の栄養補助食品成分市場は、2022年に1,745億米ドルに達し、2030年には3,275億米ドルに達するという有利な成長が予測されています。世界の栄養補助食品成分市場は、予測期間中（2023～2030年）にCAGR 8.4％を示すと予測されています。

栄養補助食品は、健康増進、老化の抑制、慢性疾患の予防、寿命の延長、身体の構造と機能のサポートなど、複数のメリットをもたらします。また、精神衛生上の懸念や病気の予防・治療にも用いられます。栄養補助食品として広く利用できるため、日常生活に簡単に取り入れることができます。栄養補助食品は、食事だけでは十分な栄養素を摂取できない人々に、シンプルな解決策を提供します。

市場力学

慢性疾患の増加

糖尿病、高血圧、がんなどの慢性疾患の有病率の上昇は、市場の成長率を押し上げると思われます。慢性疾患、特に肥満と糖尿病は、高齢者の主な悩みの種です。例えば、世界中で糖尿病の有病率が上昇していることが市場拡大の原動力となっています。国際糖尿病連合によると、2021年までに約5,370億人が糖尿病に罹患し、これは世界の10人に1人を占める。

2030年には6,430億人、2045年には7,830億人に達すると予想されています。さらに、糖尿病患者の4人に3人は低・中所得国に住んでいます。糖尿病は2021年には5秒に1人の命を奪い、全世界で約67億人の死亡者数を占める。2021年の糖尿病ヘルスケア支出は9,660億米ドルを超えると予想され、過去15年間で316％増加したことになります。このように、疾病の増加は市場成長の原動力となります。

強化食品の増加

強化食品の増加は、予測期間中に市場が成長するのに役立つ主要な要因の1つです。例えば、オーストラリアの政府機関であるCSIRO（Commonwealth Scientific and Industrial Research Organisation）によると、強化食品および機能性食品の需要は2030年までに約97億米ドルに達し、年間成長率はおよそ3%になると予測されています。世界の人口が増え続け、消費者の嗜好が変化していることから、強化・機能性食品市場の需要は堅調に推移すると予想されます。

この業界の特徴は、高齢者の消化器系や循環器系の健康のための食事から、新生児や幼児の成長のための食品まで、多様な製品構成にあることです。栄養強化・機能性食品の国内市場は2030年までに55億米ドルに達し、42億米ドルの輸出機会があると推定されます。

栄養補助食品成分の高コスト

栄養補助食品成分は、動物栄養、医薬品、機能性食品・飲料、パーソナルケア用品など、さまざまな用途に使用されています。一方、医薬品、飼料製品、飲食品、パーソナルケアアイテムに栄養補助食品成分を配合すると、最終製品の価格が上昇します。ほとんどの顧客は高価な食品の購入を避け、自然食品を好むため、最終製品の価格上昇は業界の拡大を妨げます。

COVID-19影響分析

COVID-19の大流行は、世界の栄養補助食品成分ビジネスにマイナスの影響を与えています。この流行は原料のサプライチェーンを混乱させ、欠品と価格変動をもたらしました。生産施設の閉鎖や輸送の制限も市場の成長を大きく低下させる要因となっています。パンデミックに起因する景気後退は消費者の消費力を低下させ、高価格の栄養補助食品成分への需要を低下させました。

ロシア・ウクライナ紛争の影響分析

ロシア・ウクライナ紛争は、この地域の主要な市場プレーヤーの数が少ないことから、世界の栄養補助食品成分市場に与える影響は中程度と推定されます。しかし、栄養補助食品の輸出入の影響は、予測期間中、世界の栄養補助食品成分市場の成長にほとんど影響を与えないと予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因慢性疾患の罹患率の増加
    • 強化食品の増加
  • 抑制要因
    • 栄養補助食品成分の高コスト
  • 機会
    • 栄養補助食品産業における革新
  • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

  • プロバイオティクス
  • タンパク質とアミノ酸
  • ファイトケミカルと植物抽出物
  • 繊維と特殊炭水化物
  • オメガ3脂肪酸
  • ビタミン
  • プレバイオティクス
  • カロテノイド
  • ミネラル
  • その他

第8章 形態別

  • 乾燥
  • 液体

第9章 健康効果別

  • 認知の健康
  • 腸の健康
  • 心臓の健康
  • 骨の健康
  • 免疫力
  • 栄養
  • 体重管理
  • その他

第10章 用途別

  • 食品
    • スナック
    • 菓子類
    • ベーカリー
    • 乳製品
    • 肉・肉製品
    • ベビーフード
    • その他
  • 飲料
    • エナジードリンク
    • ジュース
    • 健康飲料
    • パーソナルケア
    • 動物栄養
    • 栄養補助食品

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
      • その他アジア太平洋地域
  • 中東およびアフリカ
    • 主な地域別ダイナミクス

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Associated British Foods
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Arla Foods
  • DSM
  • Ingredients
  • Tate & Lyle
  • Ajinomoto
  • CHR. Hansen
  • Kyowa Hakko Kirin Group
  • Glanbia Plc
  • Fonterra Co-Operative Group Limited

第14章 付録

目次
Product Code: FB418

Market Overview

The Global Nutraceutical Ingredients Market reached US$ 174.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 327.5 billion by 2030. the global nutraceutical ingredients market is expected to exhibit a CAGR of 8.4% during the forecast period (2023-2030).

Nutraceuticals provide multiple benefits, including improved health, slowed ageing, prevention of chronic illnesses, increased life expectancy, and support of the body's structure and functioning. They are also used to prevent and treat mental health concerns and illnesses. Nutraceutical ingredients are widely accessible as dietary supplements, making them easy to include into one's everyday routine. They offer a simple solution for folks who may not get enough nutrients from their diet alone.

Market Dynamics

Increase in Incidence of Chronic Diseases

The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others would propel the market's growth rate. Chronic diseases, particularly obesity and diabetes, are a major source of concern among the elderly. For instance, the rising prevalence of diabetes around the world is driving market expansion. According to the International Diabetes Federation, approximately 537 Billion individuals will have diabetes by 2021, accounting for one out of every ten people worldwide.

It is expected to reach 643 Billion by 2030, and 783 Billion by 2045. Furthermore, three out of every four persons with diabetes live in low- and middle-income nations. Diabetes claimed one life every five seconds in 2021, accounting for nearly 6.7 Billion fatalities worldwide. Diabetes healthcare spending in 2021 is expected to be over $ 966 billion, representing a 316% increase over the previous 15 years. Thus rise of diseases will helps drive the market growth.

Rise in Fortified Foods

Rise in fortified foods is one of the key driver that helps the market to grow during forecast period. For instance, according to the CSIRO (Commonwealth Scientific and Industrial Research Organisation), an Australian government organisation, demand for fortified and functional foods is predicted to reach $9.7 billion by 2030, with an annual growth rate of roughly 3%. With the world's population continuing to grow and consumer preferences shifting, market demand for fortified and functional foods is expected to stay robust.

The industry is distinguished by a diverse product mix that includes everything from meals for old digestive and cardiovascular health to foods for newborn and toddler growth. The domestic market for fortified and functional goods is estimated to reach $5.5 billion by 2030, with an opportunity for exports of $4.2 billion.

High Cost of Nutraceutical Ingredients

Nutraceutical ingredients are employed in a variety of applications, including animal nutrition, medicines, functional food and drinks, and personal care items. The incorporation of nutraceutical ingredients in medicines, feed products, food and beverage goods, and personal care items, on the other hand, raises the final product price. The increasing expense of the end products stifles industry expansion since most customers avoid purchasing expensive food items in favour of natural ones.

COVID-19 Impact Analysis

The pandemic of COVID-19 has a negative impact on the worldwide nutraceutical ingredients business. The epidemic disrupted the raw material supply chain, resulting in shortages and price changes. Closures of production facilities and transportation limitations also contributed to a major reduction in market growth. The pandemic-caused economic downturn lowered consumer spending power, resulting in lower demand for high-priced nutraceutical components.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global nutraceutical ingredients market, owing to the low number of key market players in this region. However, the impact of the import and export of nutraceutical is expected to have little influence over the global nutraceutical ingredients market growth over the forecast period.

Segment Analysis

The global nutraceutical ingredients market is segmented based on product type , form, health benefits, application and region.

Proteins Product Type Segment Accounts for 32.9 % of Market Share.

Probiotics product type segment with around 32.9% is expected to dominate during the forecast period. Proteins are critical macronutrients that aid in tissue growth and repair, muscle mass maintenance, and immune system support. As a result, they are in great demand for the manufacture of nutritional supplements and functional foods.

Since, the rising incidence of lifestyle disorders such as obesity, diabetes, and cardiovascular disease has increased demand for protein-based nutraceutical products, which are recognised to aid in weight reduction, blood sugar regulation, and cardiovascular health. Plant-based protein sources such as soy, pea, and rice protein are in high demand due to the rising popularity of plant-based and vegan diets.

Furthermore, technical improvements in protein extraction and isolation techniques have made it possible to create high-quality protein components at a cheaper cost, driving the protein section of the nutraceutical ingredients market forward.

Geographical Analysis

North America Accounted for Approximately 38.4% of the Market Share 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period. North America is predicted to have good market growth since customers are willing to pay a premium for healthier items due to their increased income and buying power. With increased health and fitness concerns, there is a growing consumption of nutraceutical ingredients loaded nutritious meals. In online retail establishments, nutraceutical ingredients enriched with nutritious meals are widely available. The rapid expansion of functional beverages will drive market growth.

Competitive Landscape

The major global players in the nutraceutical ingredients market include: Associated British Foods, Arla Foods, DSM, Ingredients, Tate & Lyle, Ajinomoto, CHR. Hansen, Kyowa Hakko Kirin Group, Glanbia Plc, and Fonterra Co-Operative Group Limited.

Why Purchase the Report?

  • To visualize the global nutraceutical ingredients market segmentation based on product type, form, health benefits, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of nutraceutical ingredients market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global nutraceutical ingredients market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product Type
  • 3.2. Market Snippet By Form
  • 3.3. Market Snippet By Health Benefits
  • 3.4. Market Snippet By Application
  • 3.5. Market Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. DriversIncrease in Incidences of Chronic Diseases
    • 4.1.2. Rise in Fortified Foods
  • 4.2. Restraints
    • 4.2.1. High Cost of Nutraceutical Ingredients
  • 4.3. Opportunity
    • 4.3.1. Innovations in Nutraceutical Ingredients Industry
  • 4.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Probiotics *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Proteins and Amino Acids
  • 7.4. Phytochemical & Plant Extracts
  • 7.5. Fibers & Specialty Carbohydrates
  • 7.6. Omega-3 Fatty Acids
  • 7.7. Vitamins
  • 7.8. Prebiotic
  • 7.9. Carotenoids
  • 7.10. Minerals
  • 7.11. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Dry *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid

9. By Health Benefits

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 9.1.2. Market Attractiveness Index, By Health Benefits
  • 9.2. Cognitive Health *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Gut Health
  • 9.4. Heart Health
  • 9.5. Bone Health
  • 9.6. Immunity
  • 9.7. Nutrition
  • 9.8. Weight Management
  • 9.9. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Food *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 10.2.3. Snacks
    • 10.2.4. Confectionery
    • 10.2.5. Bakery
    • 10.2.6. Dairy
    • 10.2.7. Meat & Meat Products
    • 10.2.8. Baby Food
    • 10.2.9. Others
  • 10.3. Beverages
    • 10.3.1. Energy Drinks
    • 10.3.2. Juices
    • 10.3.3. Health Drinks
    • 10.3.4. Personal Care
    • 10.3.5. Animal Nutrition
    • 10.3.6. Dietary Supplement

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Associated British Foods *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Arla Foods
  • 13.3. DSM
  • 13.4. Ingredients
  • 13.5. Tate & Lyle
  • 13.6. Ajinomoto
  • 13.7. CHR. Hansen
  • 13.8. Kyowa Hakko Kirin Group
  • 13.9. Glanbia Plc
  • 13.10. Fonterra Co-Operative Group Limited

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us